‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JAMA Neurology Author Interviews
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease
30
00:00:00
/ 00:29:58
30